SCYNEXIS, Inc. Operating Lease Cost
SCYNEXIS, Inc. (SCYX) reported Operating Lease Cost of $664.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-04
- SCYNEXIS, Inc. operating lease, cost for the quarter ending 2024-12-31 was $166.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. operating lease, cost for the quarter ending 2024-09-30 was $166.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. operating lease, cost for the quarter ending 2024-06-30 was $166.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. operating lease, cost for the quarter ending 2024-03-31 was $166.00K, a 0.00% change year-over-year.
- SCYNEXIS, Inc. operating lease, cost for fiscal 2025 was $664.00K, a 0.00% change from fiscal 2024.
- SCYNEXIS, Inc. operating lease, cost for fiscal 2024 was $664.00K, a 0.00% change from fiscal 2023.
- SCYNEXIS, Inc. operating lease, cost for fiscal 2023 was $664.00K, a 0.00% change from fiscal 2022.
- SCYNEXIS, Inc. operating lease, cost for fiscal 2022 was $664.00K, a 0.00% change from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $664.00K 10-K · filed 2026-03-04 | |||
| 2024-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $332.00K derived: sum of 2 quarters · filed 2026-03-04 | $498.00K derived: sum of 3 quarters · filed 2026-03-04 | $664.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $166.00K 10-Q · filed 2024-11-06 | $332.00K derived: sum of 2 quarters · filed 2024-11-06 | $498.00K 10-Q · filed 2024-11-06 | $664.00K derived: sum of 4 quarters · filed 2025-03-12 |
| 2024-06-30 | $166.00K 10-Q · filed 2024-08-08 | $332.00K 10-Q · filed 2024-08-08 | $498.00K derived: sum of 3 quarters · filed 2025-03-12 | $664.00K derived: sum of 4 quarters · filed 2025-03-12 |
| 2024-03-31 | $166.00K 10-Q · filed 2024-05-08 | $332.00K derived: sum of 2 quarters · filed 2025-03-12 | $498.00K derived: sum of 3 quarters · filed 2025-03-12 | $664.00K derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $332.00K derived: sum of 2 quarters · filed 2025-03-12 | $498.00K derived: sum of 3 quarters · filed 2025-03-12 | $664.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $166.00K 10-Q · filed 2024-11-06 | $332.00K derived: sum of 2 quarters · filed 2024-11-06 | $498.00K 10-Q · filed 2024-11-06 | $664.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $166.00K 10-Q · filed 2024-08-08 | $332.00K 10-Q · filed 2024-08-08 | $498.00K derived: sum of 3 quarters · filed 2024-08-08 | $664.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $166.00K 10-Q · filed 2024-05-08 | $332.00K derived: sum of 2 quarters · filed 2024-05-08 | $498.00K derived: sum of 3 quarters · filed 2024-05-08 | $664.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $332.00K derived: sum of 2 quarters · filed 2024-03-28 | $498.00K derived: sum of 3 quarters · filed 2024-03-28 | $664.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $166.00K 10-Q · filed 2023-11-13 | $332.00K derived: sum of 2 quarters · filed 2023-11-13 | $498.00K 10-Q · filed 2023-11-13 | $664.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $166.00K 10-Q · filed 2023-08-14 | $332.00K 10-Q · filed 2023-08-14 | $498.00K derived: sum of 3 quarters · filed 2023-08-14 | $664.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $166.00K 10-Q · filed 2023-05-10 | $332.00K derived: sum of 2 quarters · filed 2023-05-10 | $498.00K derived: sum of 3 quarters · filed 2023-05-10 | $664.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $332.00K derived: sum of 2 quarters · filed 2023-03-31 | $498.00K derived: sum of 3 quarters · filed 2023-03-31 | $664.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $166.00K 10-Q · filed 2022-11-09 | $332.00K derived: sum of 2 quarters · filed 2022-11-09 | $498.00K 10-Q · filed 2022-11-09 | $664.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $166.00K 10-Q · filed 2022-08-15 | $332.00K 10-Q · filed 2022-08-15 | $498.00K derived: sum of 3 quarters · filed 2022-08-15 | $664.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $166.00K 10-Q · filed 2022-05-12 | $332.00K derived: sum of 2 quarters · filed 2022-05-12 | $498.00K derived: sum of 3 quarters · filed 2022-05-12 | $664.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $332.00K derived: sum of 2 quarters · filed 2022-03-29 | $498.00K derived: sum of 3 quarters · filed 2022-03-29 | $664.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $166.00K 10-Q · filed 2021-11-10 | $332.00K derived: sum of 2 quarters · filed 2021-11-10 | $498.00K 10-Q · filed 2021-11-10 | $664.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $166.00K 10-Q · filed 2021-08-16 | $332.00K 10-Q · filed 2021-08-16 | $498.00K derived: sum of 3 quarters · filed 2021-08-16 | $664.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $166.00K 10-Q · filed 2021-05-17 | $332.00K derived: sum of 2 quarters · filed 2021-05-17 | $498.00K derived: sum of 3 quarters · filed 2021-05-17 | $664.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $332.00K derived: sum of 2 quarters · filed 2021-03-29 | $498.00K derived: sum of 3 quarters · filed 2021-03-29 | $664.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $166.00K 10-Q · filed 2019-11-12 | $332.00K derived: sum of 2 quarters · filed 2019-11-12 | $498.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $166.00K 10-Q · filed 2019-08-07 | $332.00K 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $166.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |